<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Telomere length (TL) both reflects and limits the replicative life span of <z:mpath ids='MPATH_458'>normal</z:mpath> somatic cells </plain></SENT>
<SENT sid="1" pm="."><plain>As a consequence, critically shortened telomeres are associated with a variety of <z:mp ids='MP_0002054'>disease states</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Telomere attrition can be counteracted by a nucleoprotein complex containing telomerase </plain></SENT>
<SENT sid="3" pm="."><plain>Mutations in subunits of telomerase, telomerase-binding proteins as well as in members of the shelterin complex have been described both in inherited and acquired <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> syndromes </plain></SENT>
<SENT sid="4" pm="."><plain>Here, we report on a patient with acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and a nonsynonymous variation of codon 1062 of the hTERT gene (p.Ala1062Thr) whose substantial and maintained hematologic response to long-term <z:chebi fb="3" ids="50113">androgen</z:chebi> treatment (including complete transfusion independence) was paralleled by a significant and continued increase in TL in multilineage peripheral blood cells </plain></SENT>
<SENT sid="5" pm="."><plain>To our knowledge, this represents the first case of sustained telomere elongation in hematopoietic stem cells induced by a pharmacological approach in vivo (141 words) </plain></SENT>
</text></document>